Molecular Imaging of Human Thrombus With Novel Abciximab Immunobubbles and Ultrasound
Authors:
- 1 May 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 38 (5) , 1508-1514
Abstract
Background and Purpose— Molecular imaging of therapeutic interventions with targeted agents that simultaneously carry drugs or genes for local delivery is appealing. We investigated the ability of a novel microbubble carrier (immunobubble) for abciximab, a glycoprotein IIb/IIIa receptor inhibitor, for ultrasonographic molecular imaging of human clots. Methods— Human thrombi were incubated with immunobubbles conjugated with abciximab. Control clots were incubated in either saline or with immunobubbles conjugated with nonspecific antibody. We evaluated immunobubble suspensions with variable concentrations of encapsulated gas and measured mean acoustic intensity of the incubated clots. In vivo molecular imaging of human thrombi with abciximab immunobubbles was evaluated in a rat model of carotid artery occlusion. Results— Mean acoustic intensity was significantly higher for abciximab immunobubbles as compared with control immunobubbles under all conditions tested with maximum difference in intensity at a gas volume of 0.2 μL ( P =0.0013 for mechanical index 0.05, P =0.0001 for mechanical index 0.7). Binding of abciximab immunobubbles to clots in vitro led to enhanced echogenicity dependent on bubble concentration. In vivo ultrasonic detectability of carotid thrombi was significantly higher for clots targeted with abciximab immunobubbles ( P P P Conclusions— This study demonstrates the feasibility of using a therapeutic agent for selective targeting in vascular imaging. Abciximab immunobubbles improve visualization of human clots both in vitro and in an in vivo model of acute arterial thrombotic occlusion.Keywords
This publication has 18 references indexed in Scilit:
- Correlation of cavitation with ultrasound enhancement of thrombolysisUltrasound in Medicine & Biology, 2006
- Assessment of Endogenous and Therapeutic Arteriogenesis by Contrast Ultrasound Molecular Imaging of Integrin ExpressionCirculation, 2005
- Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic StrokeStroke, 2005
- Ultrasound-Enhanced Systemic Thrombolysis for Acute Ischemic StrokeNew England Journal of Medicine, 2004
- Intracranial Clot Lysis With Intravenous Microbubbles and Transcranial Ultrasound in SwineStroke, 2004
- Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flowJournal of Controlled Release, 2004
- Characterization of Carotid Artery Plaques Using Real-time Compound B-mode UltrasoundStroke, 2004
- Targeted-Microbubble Binding Selectively to GPIIb IIIa Receptors of Platelet ThrombiInvestigative Radiology, 2002
- Benefit of Abciximab in Patients with Refractory Unstable Angina in Relation to Serum Troponin T LevelsNew England Journal of Medicine, 1999
- Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (Abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarctionThe American Journal of Cardiology, 1996